Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Family Care Hospitals Ltd.

Family Care Hospital

Family Care Hospitals Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.

0.00

0.00 (0.00)%

EX-DatePurpose
29 06 2021 Audited Results
13 08 2021 Quarterly Results
08 11 2021 Quarterly Results & Inter alia, to appoint Dr. Sudhir Kamath (DIN: 01250059) as Non Executive Non Independent Director of the Company;
11 02 2022 Quarterly Results
28 05 2022 Rights Issue & Quarterly Results & Preferential Issue of shares & Increase in Authorised Capital & Audited Results
29 06 2022 Rights Issue & Preferential Issue of shares Inter alia, to transact the following business matters: 1. To increase the Authorised Share Capital of the Company and subsequently alter Clause V of Memorandum of Association of the Company, subject to the approval of members; 2. To change the name of the Company; 3. To consider and approve dividend for financial year 2021-22; 4. To consider proposals to raise funds by way of issuance of shares or any other instruments/ securities by way of preferential issue for meeting business and other working capital requirements. 5. To consider and evaluate proposals to raise funds by way of issuance of shares on Rights Issue basis. 6. To reconstitute Risk Management Committee. 7. To appoint M/s Mukesh Siroya and Co. Practicing Company Secretary as a scrunitzer for conducting Evoting for Postal Ballet. 8. To approve notice of 28th Annual General Meeting. 8. Any other business as the Board deemed fit to discuss, with the permission of the chair
09 07 2022 Right Issue of Equity Shares
21 10 2022 General Purpose
03 11 2022 Rights Issue Inter alia, to consider and approve the following business matters: - 1. To Approve the term w.r.t Issue of Equity Shares on Right Basis. 2. Any other business as the Board deemed fit to discuss, with the permission of the chair.
14 11 2022 Interim Dividend & Quarterly Results
28 12 2022 Right Issue of Equity Shares
13 02 2023 Quarterly Results
20 04 2023 Bonus issue(Cancelled)
20 04 2023 Bonus issue Inter alia, to consider and approve :- 1. Increase in the authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company; 2. To consider, discuss, recommend and approve Issue of Bonus shares to the equity shareholders of the Company; 3. Consider split of equity shares for better liquidity prospects for the stock. 4. Any other Business matter with the permission of the Chair.
29 05 2023 Audited Results
11 08 2023 Quarterly Results
27 10 2023 Quarterly Results
31 01 2024 Quarterly Results
20 02 2024 Issue Of Warrants
15 04 2024 Issue Of Warrants
12 11 2024 Quarterly Results
12 02 2025 Quarterly Results
24 04 2025 Preferential Issue of shares & Inter alia, to consider and evaluate a proposal for raising of funds, by way of issue of one or more instruments including equity shares, convertible securities of any description and/or warrants, on rights / preferential issue or any other permissible method and/or combination thereof as may be considered appropriate, subject to such regulatory/statutory approvals as may be required.
30 05 2025 Issue Of Warrants & Audited Results & Increase in Authorised Capital
05 08 2025 Quarterly Results
28 10 2025 Quarterly Results
20 01 2026 Quarterly Results
27 04 2026 Audited Results & Quarterly Results
02 05 2026 Quarterly Results(Cancelled) (Cancelled)
08 05 2026 Audited Results This is in connection with our previous intimation dated 22.04.2026 and 27.04.2026 informing regarding meeting of the Board of Directors of the Company scheduled to be held on 27.04.2026 through video conferencing/other audio-visual means, inter-alia to consider and approve the Standalone Audited Financial results along with Auditor s Report thereon of the Company for the financial year ended 31.03.2026 and other matters. This is to inform you that the meeting of the Board of Directors of the Company commenced today and is currently in progress. Due to the lengthy agenda and the requirement to deliberate on additional items, the Board has decided to continue the meeting on Friday, May 8, 2026. The revised date of the Board Meeting will be 08.05.2026.
12 05 2026 Audited Results

News

No Data Available

No News data available